Immunological of the Thyrotropin Receptor

Publisher Website
Google Scholar
Abstract
Antibodies to the thyrotropin receptor appear to be responsible for hyperthyroidism in Graves'' disease. The antibodies, described as thyroid-stimulating antibodies (TSAb), mimic the effects of thyrotropin (TSH) by binding to the TSH receptor and activating adenylate cyclase. TSAb consist of an electrophoretically heterogeneous population of IgG [immunoglobulin g], and the thyroid-stimulating site is formed by combination of heavy and light chains in the Fab part of the molecule. Binding studies indicate that the TSAb molecule interacts monovalently with membrane bound TSH receptors and that TSAb consists of an antibody population which shows a restricted heterogeneity with regard to TSH receptor affinity. Studies in patients with Graves'' disease and hyperthyroidism indicate that the levels of TSAb correlate well with thyroidal I uptake and the absence of pituitary control of thyroid function. In some patients with ophthalmic Graves'' disease or autoimmune thyroiditis there is evidence of serum antibodies which interact with the TSH receptor but are unable to stimulate thyroid function.